FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

23369 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some
Members targetComponentId
Burkitt lymphoma of lymph nodes of inguinal region and lower limb Burkitt lymphoma of lymph nodes of lower limb (disorder)
Burkitt's tumor of extranodal AND/OR solid organ site Burkitt's lymphoma (clinical)
Burkitt's tumor of lymph nodes of axilla AND/OR upper limb Burkitt lymphoma of lymph nodes of upper limb (disorder)
Burkitt's tumor of lymph nodes of inguinal region AND/OR lower limb Burkitt lymphoma of lymph nodes of lower limb (disorder)
Burn - unspecified Burn
Burn - unspecified Burn
Burn involving 10-14 percent of body surface, with 10-14 percent of body surface with full thickness burn Burn involving 10-19 percent of body surface, with 10-14 percent of body surface with full thickness burn (disorder)
Burn involving 15-19 percent of body surface, with 10-19 percent of body surface with full thickness burn Burn involving 10-19 percent of body surface, with 15-19 percent of body surface with full thickness burn (disorder)
Burn of cornea NOS Corneal burn
Burn of cornea NOS Corneal burn
Burn of eyelid NOS Eyelid burn
Burn of eyelid NOS Eyelid burn
Burn of internal organ NOS Burn of internal organ
Burn of internal organ NOS Burn of internal organ
Burn of other internal organ, NEC Burn of internal organ
Burn of the trunk NOS Burn of trunk
Burn of the trunk NOS Burn of trunk
Burn to arm NOS Burn of upper limb
Burn to arm NOS Burn of upper limb
Burn to cornea - erythema Corneal burn
Burn to cornea - erythema Corneal burn
Burn to head NOS Head burn (disorder)
Burn to head NOS Head burn (disorder)
Bursitis NOS Bursitis
Bursitis NOS Bursitis
Buserelin 150micrograms spray Buserelin only product
Buspirone hydrochloride 5mg tablet Buspirone hydrochloride 5 mg oral tablet
Buspirone hydrochlorine Buspirone hydrochloride (substance)
Butabarbital sodium 30mg/5mL elixir Product containing precisely secbutabarbital sodium 6 milligram/1 milliliter conventional release oral solution (clinical drug)
Butorphanol tartrate 1mg/mL injection solution ampule Butorphanol tartrate 1 mg/mL solution for injection
Butorphanol tartrate 2mg/mL injection solution ampule Butorphanol only product in parenteral dose form
Buttock random pattern flap Random pattern flap
Butyl nitrate - non-pharmaceutical Butyl nitrate
Butyrophenone derivative antipsychotic agent Butyrophenone derivative
Butyrophenone poisoning NOS Poisoning by butyrophenone-based tranquilizer
Bypass complications Complication of bypass graft
Bypass graft mechanical complications Complication of bypass graft
Bypass graft mechanical complications Complication of bypass graft
Bypass of organ NOC Construction of shunt
Byrd respirator therapy Respiratory therapy
C/O - specified symptom findings Finding reported by subject or history provider (finding)
C1 esterase inhibitor 500 units powder for injection solution 8mL vial Product containing precisely human C1 esterase inhibitor 500 unit/1 vial powder for conventional release solution for injection (clinical drug)
CAP - NOS Contraceptive cap status (finding)
CAP - NOS Contraceptive cap status (finding)
CAP used from other agency Contraceptive cap status (finding)
CAP used from other agency Contraceptive cap status (finding)
CAT scan - NOS Computed tomography (procedure)
CDC Corynebacterium group G-1 Corynebacterium accolens
CDC group DF-2 Capnocytophaga canimorsus
CDE genotype CDE haplotype (finding)
CDe genotype CDe haplotype (finding)
CNS disorders NOS Disorder of the central nervous system (disorder)
CSF appearance - NOS Cerebrospinal fluid appearance
CSF cell content NOS Cell count, cerebrospinal fluid
CSF chemistry - general NOS Determination of general chemical content of cerebrospinal fluid (procedure)
CSF exam. - general NOS Determination of general chemical content of cerebrospinal fluid (procedure)
CSF examination NOS Cerebrospinal fluid examination
CSF pressure NOS Cerebrospinal fluid pressure
CSF: chloride level NOS CSF chloride measurement
CSF: electrophoresis NOS Cerebrospinal fluid protein electrophoresis (procedure)
CSF: globulin level NOS CSF globulin measurement
CSF: microorganisms NOS Identification of microorganisms in CSF
CSF: protein level NOS Measurement of protein in cerebrospinal fluid specimen (procedure)
CTV3 ROOT SNOMED CT Concept
CVS monitoring NOS Cardiovascular monitoring
CVS monitoring NOS Cardiovascular monitoring
Ca bone/joint cartilage NOS Malignant neoplasm of skeletal system (disorder)
Ca bone/joint cartilage NOS Malignant neoplasm of skeletal system (disorder)
Ca breast - NOS Malignant neoplasm of breast (disorder)
Ca breast - NOS Malignant neoplasm of breast (disorder)
Ca cervix screening NOS Cancer cervix screening status (finding)
Ca cervix screening NOS Screening for malignant neoplasm of cervix
Ca cervix uteri NOS Malignant neoplasm of cervix uteri
Ca cervix uteri NOS Malignant neoplasm of cervix uteri
Ca colon NOS Malignant neoplasm of colon (disorder)
Ca colon NOS Malignant neoplasm of colon (disorder)
Ca esophagus NOS Malignant neoplasm of oesophagus
Ca larynx - NOS Malignant neoplasm of larynx
Ca larynx - NOS Malignant neoplasm of larynx
Ca lip, oral, pharynx NOS Malignant neoplasm of lip, oral cavity and pharynx
Ca lip, oral, pharynx NOS Malignant neoplasm of lip, oral cavity and pharynx
Ca liver/biliary system NOS Carcinoma liver and/or biliary system (disorder)
Ca liver/biliary system NOS Carcinoma liver and/or biliary system (disorder)
Ca oesophagus NOS Malignant neoplasm of oesophagus
Ca pancreas NOS Malignant neoplasm of pancreas (disorder)
Ca pancreas NOS Malignant neoplasm of pancreas (disorder)
Ca rectum + Ca anus NOS Malignant neoplasm of anorectum (disorder)
Ca rectum + Ca anus NOS Malignant neoplasm of anorectum (disorder)
Ca skin - other NOS Malignant neoplasm of skin (disorder)
Ca skin - other NOS Malignant neoplasm of skin (disorder)
Ca stomach NOS Malignant neoplasm of stomach (disorder)
Ca stomach NOS Malignant neoplasm of stomach (disorder)
Ca uterus NOS: [carcinoma] or [cancer] Malignant neoplasm of uterus (disorder)
Ca uterus NOS: [carcinoma] or [cancer] Malignant neoplasm of uterus (disorder)
Cabbage - dietary Cabbage (substance)
Cabergoline [parkinsons] Product containing cabergoline (medicinal product)
Caesarean delivery - delivered Deliveries by caesarean
Caffeine and sodium benzoate injection Product containing caffeine and sodium benzoate (medicinal product)
Caffeine containing substance - non-pharmaceutical Caffeine
Café-au-lait spots and ring chromosome 11 Ring chromosome 11 syndrome
Calcaneum X-ray Plain X-ray of calcaneum

Start Previous Page 28 of 234 Next End

Reference Sets

Reference set descriptor

Back to Start